@2024 Afarand., IRAN
ISSN: 2252-0805 The Horizon of Medical Sciences 2016;22(4):313-319
ISSN: 2252-0805 The Horizon of Medical Sciences 2016;22(4):313-319
Efficacy of Cognitive-Behavioral Stress Management Training on Symptoms Severity and Emotional Well-being of Patients with Irritable Bowel Syndrome
ARTICLE INFO
Article Type
Original ResearchAuthors
Soleymani P. (*)Abolghasemi A. (1)
Vakilee Abasaliloo S. (2)
Rahimi A. (3)
Bayramzadeh N. (4)
(*) Psychology Department, Science Faculty, Ardabil Branch, Islamic Azad University, Ardabil, Iran
(1) Psychology Department, Human Science & Literature Faculty, University of Guilan, Rasht, Iran
(2) Psychology Department, Humanity Faculty, Tabriz University, Tabriz, Iran
(3) Internal Department, Medical Faculty, Tehran University of Medical Science, Tehran, Iran
(4) Psychology Department, Science Faculty, Ardabil Branch, Islamic Azad University, Ardabil, Iran
Correspondence
Address: Andishe-ye-no Consulting and Psychological Office, Alghadir Building, Sarcheshmeh Square, Ardabil, Iran. Postal Code: 5614668149Phone: +98 (45) 33256247
Fax: +98 (45) 33337677
p62.soleymani@gmail.com
Article History
Received: December 18, 2015Accepted: July 19, 2016
ePublished: October 1, 2016
ABSTRACT
Aims
One of the most prevalent gastrointestinal functional disorders is the irritable bowel syndrome (IBS). Different medical and psychological treatments are conducted to control the symptoms of the disease. The aim of this study was to determine the effectiveness of the cognitive-behavioral stress management training on the severity of the symptoms and emotional welfare of patients with IBS.
Materials & Methods In the controlled pretest-posttest clinical trial study, 30 patients with IBS were studied in Ardabil in 2012. The subjects, selected via available sampling method, were randomly divided into two groups including experimental (n=15) and control (n=15) groups. Data was collected using the IBS severity questionnaire, the characteristic positive and negative affection scale, and the life satisfaction scale. Ten 90-minute group cognitive-behavioral stress management treatment sessions were conducted in experimental group. The subjects were assessed at both pretest and posttest steps. Data was analyzed by SPSS 20 software using multivariate covariance analysis test.
Findings The mean scores of positive affection, negative affection, life satisfaction, and IBS symptom severity of experimental and control groups were significantly different at the posttest step (p<0.001). 51%, 55%, 89%, and 57% of positive affection component, negative affection component, life satisfaction, and IBS symptom severity variances could be determined by the cognitive-behavioral stress management training, respectively.
Conclusion The cognitive-emotional stress management treatment can reduce the severity of the symptoms, while it can increase the emotional welfare, in the patients with IBS.
Materials & Methods In the controlled pretest-posttest clinical trial study, 30 patients with IBS were studied in Ardabil in 2012. The subjects, selected via available sampling method, were randomly divided into two groups including experimental (n=15) and control (n=15) groups. Data was collected using the IBS severity questionnaire, the characteristic positive and negative affection scale, and the life satisfaction scale. Ten 90-minute group cognitive-behavioral stress management treatment sessions were conducted in experimental group. The subjects were assessed at both pretest and posttest steps. Data was analyzed by SPSS 20 software using multivariate covariance analysis test.
Findings The mean scores of positive affection, negative affection, life satisfaction, and IBS symptom severity of experimental and control groups were significantly different at the posttest step (p<0.001). 51%, 55%, 89%, and 57% of positive affection component, negative affection component, life satisfaction, and IBS symptom severity variances could be determined by the cognitive-behavioral stress management training, respectively.
Conclusion The cognitive-emotional stress management treatment can reduce the severity of the symptoms, while it can increase the emotional welfare, in the patients with IBS.
CITATION LINKS
[1]Drossman DA. Introduction: The Rome Foundation and Rome III. Neurogastroenterol Motil. 2007;19(10):783-6.
[2]Canavan C, West J, Card T. Review article: The economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023-34
[3]Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics. 2001;19(6):643-53.
[4]Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71-80.
[5]Jahanghiri P, Hashemi Jazi M, Hasannzadeh Keshteli A, Sadeghpour S, Amini E, Adibi P. Irritable bowel syndrome in Iran: Sepahan systematic review. Int J Pres Med. 2012;3(1):S1-9.
[6]Hassanzadeh Keshtli A, Dehestani B, Daghaghzadeh H, Adibi P. Epidemiology features of irritable bowel syndrome and its subtypes among Iranian adults. Ann Gastroenterol. 2015;28(2):253-8.
[7]Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: Potential mechanisme of sex hormones. World J Gasstroenterol. 2014;20(22):6725-43.
[8]El-salhy M. Resent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2015;21(25):7621-36.
[9]Tillisck K, Labus JS. Advances in imaging the brain-gut axis: Functional gastrointestinal disorders. Gastroenterol. 2011;140(2):407-11.
[10]Weston AP, Biddle WL, Bhatia PS, Miner PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38(9):1590-5.
[11]Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effect of probiotics. Br J Nutr. 2002;88:S67-72.
[12]Dean BB, Aquilar D. Impairment in work productivity and health related quality of life in patient with IBS. Am J Manag. 2005;11(Suppl 1):17-26.
[13]Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development of new measure. Dig Dis Sci. 1998;43(2):400-11.
[14]Keyes CL. The mental health continuum: From languishing to flourishing in life. J Health Soc Behav. 2002;43(2):207-22.
[15]Denollet J. Standard assessment of negative affectivity, social inhibition and type D personality. Psochosom Med. 2005;61(1):89-97.
[16]Bagherian Sararoudi R, Kalantari H, Afshar H, Daghaghzadeh H, Abotalebiyan F, Falah J, et al. Relationship between negative affectivity and severity of irritable bowel syndrome symptoms. J Babol Univ Med Sci. 2012;14(2):73-81. [Persian]
[17]Muscatello MR, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affect in pathophysiology and clinical expression of irritable bowel syndrome. Word J Gastroenterol. 2014;20(24):7570-860.
[18]Bagherian Sararoodi R, Sanei H, Baghbanian A. The relationship between type D personality and perceived social support in myocardial infarction patients. J Res Med Sci. 2011;16(5):627-33.
[19]Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Psychological adjustment and autonomic disturbance in inflammatory bowel disease and irritable bowel syndrome. Psychoneuroendocrinol. 2010;35(5):653-62.
[20]Dockray S, Steptoe A. Psitive affect and psychobiological processes. Neurosci Biobehav Rev. 2010;35(1):69-75.
[21]Lex C, Bazner E, Meyer TD. Does stress play a significant role in bipolar disorder? a meta-analysis. J Affect Disord. 2016;208:298-308.
[22]Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effect of stressful life events on bowel symptoms: subject with irritable bowel syndrome compared with subject without bowel dysfunction. Gut. 1992;33(6):825-30
[23]Joc EB, Madro A, Celinski K, Slomka M, Kasztelan-Szczerbinask B, Pacian A, et al. Quality of life of patients with irritable bowel syndrome before and after education. Psychiatr Pol. 2015;49(4):821-33.
[24]Sheikhi M, Hooman HA, Ahadi H, Sepah Mansoor M. Psychometric properties of satisfaction with life scale. Andishe va Raftar. 2011;5(19):17-29. [Persian]
[25]Samadi Nazari M, Ebrahimi Daryani N, Yaraghchi A, Farrokhi N, Rezaei O. Predicting quality of life on the basis of type D Personality in patients with irritable bowel syndrome. Govaresh. 2013;18(2):80-7. [Persian]
[26]Cash BD. Emerging role of probiotics and antimicrobials in management of irritable bowel syndrome. Curr Med Res Opin. 2014; 30(7): 1405-15.
[27]Trinkley KE, Nahata MC. Treatment of irritable bowel syndrome. J Clin Pharm Ther. 2011;36(3):275-82.
[28]Zomorodi S, Rasoulzadeh Tabatabaei SK, Arbabi M, Ebrahimi Daryani N, Azad Fallah P. Comparison of the effectiveness of cognitive – behavior therapy and mindfulness based therapy on the decrease in symptoms of patients who suffer from irritable bowel syndrome. Govaresh. 2013;18(2):88-94. [Persian]
[29]Lackner JM, Jaccard J, Krasner SS, Kats LA, Gudleski CD, Holroyd, K. Self-administered cognitive behavioral therapy for modrate to sever IBS: Clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol. 2008;6(8):899-906.
[30]Mahvi-Shirazi M, Fathi-Ashttiyani A, Rasoolzade-Tabatabaee SK, Amini M. Irritable bowel syndrome treatment: Cognitive behavioral therapy versus medical treatment. Arch Med Sci. 2012;8(1):123-9.
[31]Reme SE, Kennedy T, jones R, Darnley S, Chalder T. Perdictors of treatment outcome after cognitive – behavioral therapy and antispasmodic in primary care. J Psychosom Res. 2010;68(4):385-8.
[32]Chilcot J, Moss-Morris R. Changes in illness-related cognition rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioral therapy intervention. Behav Res Ther. 2013;51(10):690-5.
[33]Kamkar A, Golzary M, Farrokhi NA, Aghaee M. The effectiveness of cognitive – behavioral stress management on symptoms of patients with Irritable bowel syndrome. Armaghan-e-Danesh. 2011;16(4):300-10. [Persian]
[34]Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol. 2013;19(46):8605-10.
[35]Ljotsson B, Folks L, Vesterlund AW, Hedman E, Lindfors L, Ruck CH, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behav Res and Ther. 2010;48(6):531-9.
[36]Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, et al. Cognitive –behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under for early-stage breast cancer. Health Psychol. 2001;20(1):20-32.
[37]Abolghasemi A, Soleymani P, Rahimi A, Vakili Abasaliloo, S. Efficacy of stress management training on symptom severity and psychological wellbeing of patient with irritable bowel syndrome. Govaresh. 2014;20(3):178-84. [Persian]
[38]Watson D, Clark L, Tallegen A. Development and validation of brief measures of positive and negative affect. The PANAS scales. J Person Soc Psycho. 1988;54(6):1063-70.
[39]Bakhshipour A, Dezhkam M. Confirmatory factor analysis of the positive affect and negative affect scales. J Psychol. 2006;9(4):65-78. [Persian]
[40]Diner E, Emmons RA, Larson RJ, Griffin S. The satisfaction of life scale. J Person Assess. 1985;49(1):71-5.
[41]Tanum L, Malt UF. Personality and physical symptoms in non psychiatric patients with functional gastrointestinal disorders. J Psychosom Res. 2001:50(3):139-46.
[42]Afshar H, Bagherian R, Foroozandeh N, Khorramian N, Daghaghzadeh H, Maracy MR, et al. The relationship between illness perception and symptom severity in patients with irritable bowel syndrome. J Isfahan Med Sch. 2011;29(137):526-36. [Persian]
[43]Mayer E. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47(6):861-69.
[44]Gomborone J, Dewsnap P, Libby G, Farthing M. Abnormal illness attitudes in patient with irritable bowel syndrome. J Psychosom Res. 1995;39(2):227-30.
[2]Canavan C, West J, Card T. Review article: The economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023-34
[3]Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics. 2001;19(6):643-53.
[4]Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71-80.
[5]Jahanghiri P, Hashemi Jazi M, Hasannzadeh Keshteli A, Sadeghpour S, Amini E, Adibi P. Irritable bowel syndrome in Iran: Sepahan systematic review. Int J Pres Med. 2012;3(1):S1-9.
[6]Hassanzadeh Keshtli A, Dehestani B, Daghaghzadeh H, Adibi P. Epidemiology features of irritable bowel syndrome and its subtypes among Iranian adults. Ann Gastroenterol. 2015;28(2):253-8.
[7]Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: Potential mechanisme of sex hormones. World J Gasstroenterol. 2014;20(22):6725-43.
[8]El-salhy M. Resent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2015;21(25):7621-36.
[9]Tillisck K, Labus JS. Advances in imaging the brain-gut axis: Functional gastrointestinal disorders. Gastroenterol. 2011;140(2):407-11.
[10]Weston AP, Biddle WL, Bhatia PS, Miner PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38(9):1590-5.
[11]Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effect of probiotics. Br J Nutr. 2002;88:S67-72.
[12]Dean BB, Aquilar D. Impairment in work productivity and health related quality of life in patient with IBS. Am J Manag. 2005;11(Suppl 1):17-26.
[13]Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development of new measure. Dig Dis Sci. 1998;43(2):400-11.
[14]Keyes CL. The mental health continuum: From languishing to flourishing in life. J Health Soc Behav. 2002;43(2):207-22.
[15]Denollet J. Standard assessment of negative affectivity, social inhibition and type D personality. Psochosom Med. 2005;61(1):89-97.
[16]Bagherian Sararoudi R, Kalantari H, Afshar H, Daghaghzadeh H, Abotalebiyan F, Falah J, et al. Relationship between negative affectivity and severity of irritable bowel syndrome symptoms. J Babol Univ Med Sci. 2012;14(2):73-81. [Persian]
[17]Muscatello MR, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affect in pathophysiology and clinical expression of irritable bowel syndrome. Word J Gastroenterol. 2014;20(24):7570-860.
[18]Bagherian Sararoodi R, Sanei H, Baghbanian A. The relationship between type D personality and perceived social support in myocardial infarction patients. J Res Med Sci. 2011;16(5):627-33.
[19]Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Psychological adjustment and autonomic disturbance in inflammatory bowel disease and irritable bowel syndrome. Psychoneuroendocrinol. 2010;35(5):653-62.
[20]Dockray S, Steptoe A. Psitive affect and psychobiological processes. Neurosci Biobehav Rev. 2010;35(1):69-75.
[21]Lex C, Bazner E, Meyer TD. Does stress play a significant role in bipolar disorder? a meta-analysis. J Affect Disord. 2016;208:298-308.
[22]Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effect of stressful life events on bowel symptoms: subject with irritable bowel syndrome compared with subject without bowel dysfunction. Gut. 1992;33(6):825-30
[23]Joc EB, Madro A, Celinski K, Slomka M, Kasztelan-Szczerbinask B, Pacian A, et al. Quality of life of patients with irritable bowel syndrome before and after education. Psychiatr Pol. 2015;49(4):821-33.
[24]Sheikhi M, Hooman HA, Ahadi H, Sepah Mansoor M. Psychometric properties of satisfaction with life scale. Andishe va Raftar. 2011;5(19):17-29. [Persian]
[25]Samadi Nazari M, Ebrahimi Daryani N, Yaraghchi A, Farrokhi N, Rezaei O. Predicting quality of life on the basis of type D Personality in patients with irritable bowel syndrome. Govaresh. 2013;18(2):80-7. [Persian]
[26]Cash BD. Emerging role of probiotics and antimicrobials in management of irritable bowel syndrome. Curr Med Res Opin. 2014; 30(7): 1405-15.
[27]Trinkley KE, Nahata MC. Treatment of irritable bowel syndrome. J Clin Pharm Ther. 2011;36(3):275-82.
[28]Zomorodi S, Rasoulzadeh Tabatabaei SK, Arbabi M, Ebrahimi Daryani N, Azad Fallah P. Comparison of the effectiveness of cognitive – behavior therapy and mindfulness based therapy on the decrease in symptoms of patients who suffer from irritable bowel syndrome. Govaresh. 2013;18(2):88-94. [Persian]
[29]Lackner JM, Jaccard J, Krasner SS, Kats LA, Gudleski CD, Holroyd, K. Self-administered cognitive behavioral therapy for modrate to sever IBS: Clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol. 2008;6(8):899-906.
[30]Mahvi-Shirazi M, Fathi-Ashttiyani A, Rasoolzade-Tabatabaee SK, Amini M. Irritable bowel syndrome treatment: Cognitive behavioral therapy versus medical treatment. Arch Med Sci. 2012;8(1):123-9.
[31]Reme SE, Kennedy T, jones R, Darnley S, Chalder T. Perdictors of treatment outcome after cognitive – behavioral therapy and antispasmodic in primary care. J Psychosom Res. 2010;68(4):385-8.
[32]Chilcot J, Moss-Morris R. Changes in illness-related cognition rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioral therapy intervention. Behav Res Ther. 2013;51(10):690-5.
[33]Kamkar A, Golzary M, Farrokhi NA, Aghaee M. The effectiveness of cognitive – behavioral stress management on symptoms of patients with Irritable bowel syndrome. Armaghan-e-Danesh. 2011;16(4):300-10. [Persian]
[34]Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol. 2013;19(46):8605-10.
[35]Ljotsson B, Folks L, Vesterlund AW, Hedman E, Lindfors L, Ruck CH, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behav Res and Ther. 2010;48(6):531-9.
[36]Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, et al. Cognitive –behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under for early-stage breast cancer. Health Psychol. 2001;20(1):20-32.
[37]Abolghasemi A, Soleymani P, Rahimi A, Vakili Abasaliloo, S. Efficacy of stress management training on symptom severity and psychological wellbeing of patient with irritable bowel syndrome. Govaresh. 2014;20(3):178-84. [Persian]
[38]Watson D, Clark L, Tallegen A. Development and validation of brief measures of positive and negative affect. The PANAS scales. J Person Soc Psycho. 1988;54(6):1063-70.
[39]Bakhshipour A, Dezhkam M. Confirmatory factor analysis of the positive affect and negative affect scales. J Psychol. 2006;9(4):65-78. [Persian]
[40]Diner E, Emmons RA, Larson RJ, Griffin S. The satisfaction of life scale. J Person Assess. 1985;49(1):71-5.
[41]Tanum L, Malt UF. Personality and physical symptoms in non psychiatric patients with functional gastrointestinal disorders. J Psychosom Res. 2001:50(3):139-46.
[42]Afshar H, Bagherian R, Foroozandeh N, Khorramian N, Daghaghzadeh H, Maracy MR, et al. The relationship between illness perception and symptom severity in patients with irritable bowel syndrome. J Isfahan Med Sch. 2011;29(137):526-36. [Persian]
[43]Mayer E. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47(6):861-69.
[44]Gomborone J, Dewsnap P, Libby G, Farthing M. Abnormal illness attitudes in patient with irritable bowel syndrome. J Psychosom Res. 1995;39(2):227-30.